Click Therapeuticsincis A Leader In Digital Therapeuticsfocusing On The Development And Commercialization Of Software As Prescription Medical Treatmentsfounded In 2012 And Based In New Yorkthe Company Aims To Meet Unmet Medical Needs Through Cognitive And Neurobehavioral Mechanismsits Digital Therapeutics Can Be Used Independently Or Alongside Traditional Biomedical Treatments The Company Offers A Variety Of Digital Therapeutic Productsincluding Mobile Apps That Healthcare Providers Can Prescribethese Products Utilize The Clickometricsaadaptive Data Science Platform To Personalize User Experiences And Improve Outcomesnotable Offerings Include A Smoking Cessation Program And A Prescription Digital Therapeutic For Major Depressive Disorder Symptomsboth Of Which Have Received Fda Clearanceclick Therapeutics Has Also Expanded Its Portfolio With New Products Like Click Sea C With A Strong Presence In The Healthcare Sectorclick Therapeutics Collaborates With Various Payersprovidersand Employers Across The United Statesthe Company Has Successfully Raised Significant Fundingtotaling Over $142 Millionto Support Its Growth And Innovation In The Digital Therapeutics Space
United States
